Bone Cancer

Zoledronic acid (Zometa)

This slideshow reviews zoledronic acid (Zometa), indicated for pain reduction associated with bone metastases, hypercalcemia of malignancy, and osteolytic lesions of multiple myeloma.

Next post in Web Exclusives